• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Bristol Myers Squibb to Take Part in the 7th Annual Truist Life Sciences Summit

    Investing News Network
    Apr. 27, 2021 08:59PM PST
    Biotech Investing
    Bristol Myers Squibb today announced that the company will participate in a fireside chat at the 7 th Annual Virtual Truist Life Sciences Summit, which will be webcast on Wednesday, May 5, 2021. Adam Lenkowsky, Senior Vice President, General Manager of U.S. Oncology, Immunology and CV and Winselow Tucker, Senior Vice President, General Manager, U.S. Hematology will answer questions about the company at 8 a.m. ET. ...

    Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in a fireside chat at the 7 th Annual Virtual Truist Life Sciences Summit, which will be webcast on Wednesday, May 5, 2021. Adam Lenkowsky, Senior Vice President, General Manager of U.S. Oncology, Immunology and CV and Winselow Tucker, Senior Vice President, General Manager, U.S. Hematology will answer questions about the company at 8 a.m. ET.

    Investors and the general public are invited to listen to a live webcast of the session at https://investor.bms.com . An archived edition of the session will be available later that day.

    About Bristol Myers Squibb

    Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn , Twitter , YouTube , Facebook , and Instagram .

    corporatefinancial-news

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210428005109/en/

    Bristol Myers Squibb

    Media:
    media@bms.com

    Investor Relations:
    Tim Power
    609-252-7509
    timothy.power@bms.com

    Nina Goworek
    908-673-9711
    nina.goworek@bms.com

    News Provided by Business Wire via QuoteMedia

    The Conversation (0)

    Latest News

    SVN-SDN-14 PTSD Programme - Positive pre-clinical results with three high-performing candidates advancing to in vivo studies

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×